CAVAZZA PAOLO 4
4 · SCICLONE PHARMACEUTICALS INC · Filed May 2, 2012
Insider Transaction Report
Form 4
CAVAZZA PAOLO
10% Owner
Transactions
- Sale
Common Stock
2012-04-30$5.25/sh−6,328,469$33,224,462→ 252,469 total(indirect: I) - Disposition to Issuer
Common Stock
2012-04-30$5.25/sh−252,469$1,325,462→ 513,372 total(indirect: I) - Disposition to Issuer
Common Stock
2012-04-30$5.25/sh−252,469$1,325,462→ 0 total(indirect: I) - Disposition to Issuer
Common Stock
2012-04-30$5.25/sh−147,531$774,538→ 1,141,521 total(indirect: I)
Holdings
- 822,815
Common Stock
Footnotes (3)
- [F1]Shares directly owned by Defiante Farmaceutica S.A. ("Defiante"). Defiante is 58% directly owned by Sigma-Tau Finanziaria S.p.A. ("Sigma-Tau") and 42% directly owned by Sigma-Tau's wholly-owned subsidiary Sigma-Tau International S.A. Paolo Cavazza directly and indirectly owns 38% of Sigma-Tau.
- [F2]Shares directly owned by Aptafin S.p.A. ("Aptafin"). Aptafin is owned by Paolo Cavazza and members of his family.
- [F3]Shares directly owned by Sinaf S.A. ("Sinaf"). Sinaf is 100% directly owned by Aptafin.